Testing effectiveness (Phase 2)Study completedNCT02312011
What this trial is testing
A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1
Who this might be right for
Myotonic Dystrophy Type 1
Ionis Pharmaceuticals, Inc. 48